Intimation of Newspaper Publication on 1st November 2025 w.r.t. Unaudited Financial Results for the quarter and half year ended 30th September 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bombay Oxygen Investments Ltd (BSE Scrip Code: 509470) has filed an intimation under SEBI Listing Regulations 30 and 47, attaching copies of the unaudited financial results for Q2 and H1 FY26 (quarter and half year ended 30 September 2025) as published in the Free Press Journal (English) and Navshakti (Marathi) on 1 November 2025. The Board of Directors approved these results at its meeting on 31 October 2025, after they were reviewed by the Audit Committee and the statutory auditors as required under Regulation 33 of SEBI LODR. The results are prepared under Ind AS. From the published extract, the company's equity share capital is Rs. 150 lakhs (face value Rs. 100 per share), and the comparative figures show that while the company reported a loss per share of Rs. 347.76 in FY25 (with Total Comprehensive Loss around Rs. 521.64 lakhs), the current period figures indicate a return to profitability with positive EPS values in the recent quarters.
This is a routine regulatory disclosure required under SEBI Listing Regulations to ensure public dissemination of quarterly results through newspaper publication. No new material information beyond what is already in the published extract; investors should review the detailed results on BSE (www.bseindia.com) or the company's website (www.bomoxy.com) for thorough analysis.